Published in J Neurosurg on April 01, 1988
Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. | NCT05131295
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 3.32
The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol (2012) 1.84
Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2011) 1.58
Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol (2013) 1.54
Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res (2013) 1.49
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care (2007) 1.42
Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab (2011) 1.19
Management of cerebral vasospasm. Neurosurg Rev (2006) 1.18
Clinical trials for cytoprotection in stroke. NeuroRx (2004) 1.08
Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol (2013) 1.04
Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage. Can J Hosp Pharm (2014) 0.93
Management of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1993) 0.93
Neuroprotection in subarachnoid hemorrhage. Stroke (2010) 0.92
Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions. Neurol Res Int (2013) 0.89
Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurotherapeutics (2012) 0.89
Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand? Neurol Res Int (2013) 0.82
Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage. Ann Intensive Care (2011) 0.81
Role of gap junctions in early brain injury following subarachnoid hemorrhage. Brain Res (2009) 0.79
The critical care management of poor-grade subarachnoid haemorrhage. Crit Care (2016) 0.77
Subarachnoid hemorrhage in the African-American population: a cooperative study. J Natl Med Assoc (1997) 0.75
Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. F1000Res (2015) 0.75
Sinus arrest after nimodipine treatment for a head injury. Tex Heart Inst J (1994) 0.75
Dysregulation of oxygen hemodynamic responses to synaptic train stimulation in a rat hippocampal model of subarachnoid hemorrhage. J Cereb Blood Flow Metab (2015) 0.75
Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future. Stroke Res Treat (2013) 0.75
Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions? Hosp Pharm (2014) 0.75
Differing calcium sensitivities of human cerebral and digital arteries, human metatarsal veins, and rat aorta. Br J Clin Pharmacol (1991) 0.75
High Compliance with Scheduled Nimodipine Is Associated with Better Outcome in Aneurysmal Subarachnoid Hemorrhage Patients Cotreated with Heparin Infusion. Front Neurol (2017) 0.75
Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm. A case report. Interv Neuroradiol (2004) 0.75
Ethical considerations in neuroclinical trials. Neurosurg Rev (1997) 0.75
Changing practices in neuroanaesthesia. Can J Anaesth (1990) 0.75
On the effect of calcium antagonists on cerebral blood flow in rats. A comparison of nimodipine and flunarizine. Neurosurg Rev (1997) 0.75
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol (2001) 5.03
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (1986) 4.35
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene (2001) 3.44
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Simplified silver-plating stain for flagella. J Clin Microbiol (1977) 3.37
What more do we have to do? Br Dent J (1992) 3.12
Vive la difference. Br Dent J (2001) 3.01
Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Establishment of a prophylactic program. Med J Aust (1993) 2.70
Student debt. Br Dent J (1995) 2.65
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med (1983) 2.63
One-year outcome of elderly and young patients admitted to intensive care units. Crit Care Med (1993) 2.58
A novel role for Rab5-GDI in ligand sequestration into clathrin-coated pits. Curr Biol (1998) 2.39
Quality of life measures before and one year after admission to an intensive care unit. Crit Care Med (1995) 2.35
A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet (1999) 2.15
Group I and group II introns. FASEB J (1993) 2.11
Dentists in the chair. Br Dent J (1998) 2.04
Future of the CDS. Community Dental Service. Br Dent J (1997) 2.03
How much does it cost? Br Dent J (2001) 2.03
The first step. Br Dent J (1994) 2.03
Want or need? Br Dent J (1995) 2.03
The scientific method. Br Dent J (1994) 2.03
Paradigm busters. Br Dent J (1997) 2.02
Nothing but the evidence. Br Dent J (1998) 2.02
The dentist's responsibility? Br Dent J (1993) 2.01
Fraud in dentistry. Br Dent J (1998) 2.00
A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke (1991) 1.97
Time course of vasospasm in man. J Neurosurg (1978) 1.93
NHS or private--a balanced choice. Br Dent J (1996) 1.93
Safety in radiation. Br Dent J (1992) 1.92
Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J Virol (1999) 1.92
Clinically essential. Br Dent J (1995) 1.91
Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery (1997) 1.90
Lateral canthal advancement of the supraorbital margin. A new corrective technique in the treatment of coronal synostosis. J Neurosurg (1976) 1.87
Chemical synthesis and expression of a cassette adapted ubiquitin gene. J Biol Chem (1987) 1.84
Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol (1982) 1.79
Heritability of the timing of autumn migration in a natural bird population. Proc Biol Sci (2001) 1.78
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol (1997) 1.77
Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J Infect Dis (1988) 1.75
Cigarette smoking and diabetic retinopathy. Diabetes (1977) 1.71
Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol (1997) 1.69
Cost accounting of adult intensive care: methods and human and capital inputs. Crit Care Med (1996) 1.65
In vitro evidence for homologous recombinational repair in resistance to melphalan. J Natl Cancer Inst (2001) 1.65
Bayesian analysis of mixtures applied to post-synaptic potential fluctuations. J Neurosci Methods (1993) 1.61
A tyrosyl-tRNA synthetase protein induces tertiary folding of the group I intron catalytic core. J Mol Biol (1996) 1.60
Traumatic cerebral aneurysms. Clinical features and natural history. J Neurol Neurosurg Psychiatry (1973) 1.57
Predicting recovery of facial nerve function following injury from a basilar skull fracture. J Neurosurg (1991) 1.55
Central neurogenic tumours of the thoracic region. Can J Surg (1992) 1.53
Etiology of cerebral vasospasm in primates. J Neurosurg (1991) 1.53
Survival of patients treated for end-stage renal disease by dialysis and transplantation. Can Med Assoc J (1977) 1.52
Peripheral nerve injection injury with steroid agents. Plast Reconstr Surg (1982) 1.52
Slit ventricle syndrome with aqueduct stenosis: third ventriculostomy as definitive treatment. Neurosurgery (1988) 1.51
Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness. Br J Cancer (2003) 1.51
Breast cancer in northern Alberta: pilot study in computerized registration. Can Med Assoc J (1977) 1.51
Genetic and environmental contributions to size, color, shape, and other characteristics of melanocytic naevi in a sample of adolescent twins. Genet Epidemiol (1999) 1.51
Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis (1992) 1.50
Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J Virol (1997) 1.49
Spinal subdural hematoma. A review. Surg Neurol (1983) 1.48
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci U S A (1999) 1.47
Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol (1992) 1.47
The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg (1983) 1.46
Estrogen use and cancer of the uterine corpus in Alberta. Can Med Assoc J (1978) 1.46
Traumatic intracranial aneurysms. J Neurosurg (1980) 1.44
Functional impact of remodeling during healing after non-Q wave versus Q wave anterior myocardial infarction in the dog. J Am Coll Cardiol (1992) 1.44
Flumazenil in drug overdose: randomized, placebo-controlled study to assess cost effectiveness. Crit Care Med (1999) 1.43
Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys. J Neurosurg (1992) 1.43
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis (2005) 1.42
Protein synthesis in rabbit reticulocytes: mechanism of protein synthesis inhibition by heme-regulated inhibitor. Proc Natl Acad Sci U S A (1979) 1.41
Pituitary apoplexy associated with a triple bolus test. Case report. J Neurosurg (1984) 1.41
Scanning electron microscopy of normal and vasospastic monkey cerebrovascular smooth muscle cells. Neurosurgery (1991) 1.41
Monitoring renal transplants: an application of the multiprocess Kalman filter. Biometrics (1983) 1.41
Recovery characteristics following induction of anaesthesia with a combination of thiopentone and propofol. Can J Anaesth (1994) 1.41
Adult diastematomyelia. Can J Neurol Sci (1994) 1.41
Complete recovery after profound acidosis (pH 6.49). Arch Dis Child (1984) 1.40
A licence to learn. Br Dent J (1997) 1.40
Flap selection in cranial base reconstruction. Plast Reconstr Surg (1996) 1.40
Gamma knife radiosurgery for large vestibular schwannomas: a Canadian experience. Can J Neurol Sci (2013) 1.39
Midwives and maternal and child health: building resource capacity. J Midwifery Womens Health (2001) 1.39
The power of prevention. Br Dent J (1995) 1.38
Gauze-induced granuloma ("gauzoma"): an uncommon complication of gauze reinforcement of berry aneurysms. J Neurosurg (1990) 1.38
Teamwork marketing. Br Dent J (1994) 1.38
Law and ethics. Br Dent J (1994) 1.38
The continuing saga. Br Dent J (1997) 1.37
Formation of 8-hydroxydeoxyguanosine, hydroxyl free radical adduct of DNA in granulocytes exposed to the tumor promoter, tetradecanoylphorbolacetate. Biochem Biophys Res Commun (1986) 1.36
Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia. Neurosurgery (2000) 1.35
Multilevel anterior cervical corpectomy and fibular allograft fusion for cervical myelopathy. J Neurosurg (1997) 1.34
Management of acute subdural hematomas from aneurysmal rupture. Can J Neurol Sci (1984) 1.33
Characterization of the heme and pyridoxal phosphate cofactors of human cystathionine beta-synthase reveals nonequivalent active sites. Biochemistry (1999) 1.33
Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol (1991) 1.32
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol (1988) 1.31
Nitrate reductase-mediated synthesis of silver nanoparticles from AgNO3. Biotechnol Lett (2007) 1.30
Relative accuracy of clinical examination and mammography in a breast clinic in Alberta. J Can Assoc Radiol (1978) 1.29
The development and preliminary validation of a new measure of adult attachment: the adult attachment projective. Attach Hum Dev (2001) 1.28
Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. Circulation (1996) 1.27
Subtemporal decompression for the slit-ventricle syndrome after shunting in hydrocephalic children. Childs Brain (1979) 1.25
Group II intron mobility in yeast mitochondria: target DNA-primed reverse transcription activity of aI1 and reverse splicing into DNA transposition sites in vitro. J Mol Biol (1998) 1.23
Hydrogen sulfide poisoning: review of 5 years' experience. Can Med Assoc J (1977) 1.23